VasDeBlock medical ApS: Financial statements 2022
CVR: 37525758
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
VasDeBlock medical ApS (CVR 37525758) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -96,664 and a net result of DKK -112,464 compared with DKK -83,457 the year before. Equity in the 2022 report amounted to DKK 32,247. The solvency ratio was 100%.
- Revenue
- DKK 0
- Gross Profit
- DKK -96,664
- Profit/Loss
- DKK -112,464
- Equity
- DKK 32,247
- Total Assets
- DKK 32,246
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | 0 | -97K | -112K | 32K | - |
| 2021 | 0 | -68K | -83K | 51K | - |
| 2020 | 0 | -247K | -263K | 74K | - |
| 2019 | 17K | -33K | -48K | 70K | - |
| 2018 | 33K | -33K | -49K | 118K | - |
Official annual report
Keep an eye on VasDeBlock medical ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
VasDeBlock medical ApS has published its annual report for 2021. Revenue came to DKK 0, and the net result was DKK -83,457.
About VasDeBlock medical ApS
VasDeBlock medical ApS is a Danish company of the type Anpartsselskab based in Karise, founded in 2016. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Mette Mikkelsen. The board consists of Nickolei Henrik Nagel (chair), Anders Brummerstedt-Madsen, Henrik Harboe and Niels Bøggild Lindeburg. The company's owners include Mette Mikkelsen, Nickolei Henrik Nagel and HOLDINGSELSKABET TEG AF 2011 ApS. In 2025, the company reported a gross profit of DKK -103,154 and a net result of DKK -103,099 compared with DKK -76,186 the year before. Equity in the 2025 report amounted to DKK 79,417.